CM

A comparison of two foreign banks shows that Banco Bilbao (BBVA) presents a better value opportunity than Canadian Imperial Bank (CM). Both stocks have a Zacks Rank #2 (Buy) with positive earnings outlooks, but BBVA outperforms on valuation metrics with a forward P/E of 10.45 versus CM's 14.71, a PEG ratio of 0.66 versus 1.10, and a P/B ratio of 1.9 versus 2.4. BBVA earned a Value grade of A compared to CM's D grade.

PharmaCorp Rx Inc. completed the acquisition of a PharmaChoice Canada-bannered pharmacy in Western Canada for $1.3 million and acquired prescription files from an I.D.A.-bannered pharmacy for $475,000, bringing its total store count to 17 pharmacies. The company also increased its credit facility with Canadian Imperial Bank of Commerce from $17.5 million to $27.5 million and has a non-binding letter of intent to acquire three additional PharmaChoice Canada-bannered pharmacies in Atlantic Canada.

A comparison of two foreign banks shows Banco Bilbao (BBVA) presents a better value opportunity than Canadian Imperial Bank (CM). BBVA has a higher Zacks Rank (#2 Buy vs #3 Hold), more attractive valuation metrics including a lower forward P/E ratio (11.54 vs 14.49) and PEG ratio (0.73 vs 1.09), and a stronger Value grade (A vs D).

Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, effective until November 7, 2028, allowing the company to issue up to $600 million in Class A and Preferred Shares through the TSX. The program will be administered by National Bank Financial Inc., with proceeds to be invested in a portfolio of 14 leading Canadian dividend-yielding stocks.